Lunai Bioworks (LNAI) Other Working Capital Changes (2016 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Other Working Capital Changes of $111378.0 in Q1 2026, down 43.69% quarter-over-quarter from $197797.0 in Q4 2025, and up 4175.3% on a YoY basis from $2605.1 in Q1 2025.
Lunai Bioworks (LNAI) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Lunai Bioworks' Other Working Capital Changes history runs 11 years deep, the most recent figure standing at $111378.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 4175.3% year-over-year to $111378.0; the TTM figure through Mar 2026 stood at $37179.0 (down 95.33% YoY), while the FY2025 annual figure was -$16086.0, down 242.56% from the prior year.
- Other Working Capital Changes was $111378.0 for Q1 2026 at Lunai Bioworks, down from $197797.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $810025.0 in Q2 2024 to a low of -$784154.0 in Q1 2024.
- Historically, Other Working Capital Changes has averaged -$88721.3 across 5 years, with a median of -$97232.0 in 2022.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes tumbled 1603.56% in 2022, then surged 10377.0% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at -$185530.0 in 2022, then jumped by 100.89% to $1652.0 in 2023, then soared by 10377.0% to $173080.0 in 2024, then climbed by 14.28% to $197797.0 in 2025, then tumbled by 43.69% to $111378.0 in 2026.
- The last three Other Working Capital Changes figures came in at $111378.0 (Q1 2026), $197797.0 (Q4 2025), and -$269264.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111,378.00 |
| Mar 31, 2026 | 111,378.00 |
| Dec 31, 2025 | 197,797.00 |
| Dec 31, 2025 | 197,797.00 |
| Sep 30, 2025 | -269,264.00 |
| Sep 30, 2025 | -269,264.00 |
| Jun 30, 2025 | -2,732.00 |
| Jun 30, 2025 | -2,732.00 |
| Mar 31, 2025 | -2,733.00 |
| Mar 31, 2025 | -2,733.00 |
| Dec 31, 2024 | 173,080.00 |
| Dec 31, 2024 | 173,080.00 |
| Sep 30, 2024 | -183,701.00 |
| Sep 30, 2024 | -183,701.00 |
| Jun 30, 2024 | 810,025.00 |
| Jun 30, 2024 | 810,025.00 |
| Mar 31, 2024 | -784,154.00 |
| Mar 31, 2024 | -784,154.00 |
| Dec 31, 2023 | 1,652.00 |
| Dec 31, 2023 | 1,652.00 |